Research on Primary HIV Infection
 Journal Club: In Early HIV Infection, Little Reason to Delay Therapy (January 8, 2012)
From Journal Watch
- SPARTAC Trial: Treatment in Primary Infection for 48 Weeks Shows Small Delay in Disease Progression (July/August 2011)
To read PDF, click here.
In HIV Treatment Bulletin, from HIV i-Base
- HIV Treatment in Primary Infection: 48-Week Course Modestly Delays CD4 Drop (July 20, 2011)
From aidsmap.com
- Symptomatic Primary HIV Infection in a 49-Year-Old Man Who Has Sex With Men: Beware the Window Phase (December 16, 2009)
In CDC HIV/Hepatitis/STD/TB Prevention News Update, from U.S. Centers for Disease Control and Prevention
- HIV's Silent Dangers Make Early HIV Treatment Critical, Expert Says (July 21, 2009)
A discussion about inflammation, early treatment and universal treatment access -- Wafaa El-Sadr, M.D., M.P.H., United States.
In The 5th International AIDS Society Conference on HIV Pathogenesis, Treatment and Prevention, from The Body PRO
- RNA Test to Detect HIV During Acute, Primary Phase Not Widely Used, New York Times Reports (May 1, 2009)
In Kaiser Daily HIV/AIDS Report, from Henry J. Kaiser Family Foundation
- Unique, Statewide Program of Acute HIV Testing and Partner Outreach Finds That Many Acute Infections in North Carolina May Stem From Exposure to Chronically Infected Patients (February 5, 2008)
An Interview With Sandra McCoy, Ph.D.
From The Body PRO
- HIV Viral Load in Semen Is Highest Three to Four Weeks After Infection, Study Says (August 28, 2007)
From aidsmap.com
- Three Months of Meds in Early Infection May Slow Down HIV in the Long Run (June 26, 2007)
From aidsmap.com
- An Overview of the Pathogenesis and Treatment of Primary HIV Infection (September 28, 2006)
In 46th Interscience Conference on Antimicrobial Agents and Chemotherapy
- Does Early Treatment of Primary HIV Infection Delay Treatment Indication? (August 14, 2006)
In XVI International AIDS Conference
- Seroreversion in Subjects Receiving Antiretroviral Therapy During Acute/Early HIV Infection (PDF) (March 1, 2006)
In Clinical Infectious Diseases
- Detecting Primary HIV Infection: Important for Prevention and, Extremely Rarely, Treatment as Well (February 7, 2006)
In The 13th Conference on Retroviruses and Opportunistic Infections
- HIV Transmission Highest During Acute Infection and End-Stage Disease (January 2006)
Part of David Wohl, M.D.'s review of the top 10 HIV research reports of 2005.
In HIV JournalView, from The Body PRO
- HIV JournalView: A Novel -- and Essential -- Method for Spotting Acute HIV Infections (January 2006)
Part of David Wohl, M.D.'s review of the top 10 HIV research reports of 2005.
In HIV JournalView, from The Body PRO
- HIV JournalView: Reducing Latent HIV Reservoirs (January 2006)
Part of David Wohl, M.D.'s review of the top 10 HIV research reports of 2005.
In HIV JournalView, from The Body PRO
- Acute HIV Infection: A Unique Opportunity to Intervene (February 25, 2005)
[Archived Article]
In The 12th Conference on Retroviruses and Opportunistic Infections, from The Body PRO
- HAART During Acute Infection Does Not Confer Long-Term Virologic Benefit, Study Suggests (November 2004)
[Archived Article]
Full text of a study by Bruce Walker, M.D., and colleagues.
In PLoS Medicine
- HIV JournalView: Primary Drug Resistance Can Persist a Year or More (September 2004)
[Archived Article]
From The Body PRO
- Negative HIV Antibody Test Results Among People Treated During Acute/Early Infection (July 12, 2004)
[Archived Article]
In The XV International AIDS Conference, from The Body PRO
- Rapid Clearance of HIV After Acute Infection Linked to Lower Risk of Disease Progression (May 11, 2004)
[Archived Article]
In CDC HIV/Hepatitis/STD/TB Prevention News Update, from U.S. Centers for Disease Control and Prevention
- Little Benefit Seen for Treatment During Acute Infection (February 9, 2004)
[Archived Article]
In The 11th Conference on Retroviruses and Opportunistic Infections, from The Body PRO
- Losing Control: Breakthroughs in Bruce Walker's Acute Infection Cohort (May 2003)
[Archived Article]
In TAGline, from Treatment Action Group
- Is HAART for Primary/Early HIV Infection Associated With Improved Outcomes After Treatment Discontinuation? (February 13, 2003)
[Archived Article]
In The 10th Conference on Retroviruses and Opportunistic Infections, from The Body PRO
- The QUEST Cohort: Treatment of Primary HIV Infection With Quadruple HAART: Week 48 Preliminary Results (February 13, 2003)
[Archived Article]
In The 10th Conference on Retroviruses and Opportunistic Infections, from The Body PRO
- High Replication Capacity Is Associated With High Baseline Viral Load in Untreated Subjects With Primary HIV Infection (February 13, 2003)
[Archived Article]
In The 10th Conference on Retroviruses and Opportunistic Infections, from The Body PRO
- Antiretroviral Resistance Among Patients With Primary HIV Infection in the Southeastern U.S. -- Impact on Treatment Outcome (February 11, 2003)
[Archived Article]
In The 10th Conference on Retroviruses and Opportunistic Infections, from The Body PRO
- Primary HIV-1 Infection in African Children Infected Through Breastfeeding (December 30, 2002)
[Archived Article]
In CDC HIV/Hepatitis/STD/TB Prevention News Update, from U.S. Centers for Disease Control and Prevention
- New University of North Carolina Study Reveals Screening Tests Can Boost Early Discovery of AIDS Virus (August 13, 2002)
[Archived Article]
In CDC HIV/Hepatitis/STD/TB Prevention News Update, from U.S. Centers for Disease Control and Prevention
- Antiretroviral-Drug Resistance Among Patients Recently Infected With HIV (August 8, 2002)
[Archived Article]
Greater primary resistance necessitates earlier drug-resistance testing, researchers say.
In CDC HIV/Hepatitis/STD/TB Prevention News Update, from U.S. Centers for Disease Control and Prevention
- Is Simplification to Triple Antiretroviral Therapy After Viral Suppression With Quadruple Therapy Initiated at the Time of Primary Infection Associated With Increased Low-Level Viral Breakthrough? (July 11, 2002)
[Archived Article]
In The XIV International AIDS Conference, from The Body PRO
- A Synergistic Effect of HIV and CMV Infection/Reactivation on Response to HAART and Plasma CD8+/CD38+ But Not CD4+ Cell Populations in Patients With Primary HIV Infection (July 10, 2002)
[Archived Article]
In The XIV International AIDS Conference, from The Body PRO
- When to Start Antiretroviral Therapy? (February 26, 2002)
[Archived Article]
In The 9th Conference on Retroviruses and Opportunistic Infections, from The Body PRO
- HIV Highly Contagious Before Symptoms Show (January/February 2002)
[Archived Article]
In Body Positive, from Body Positive
- Can Treatment During Primary HIV Infection Lead to Control of Disease Without Drugs? (Winter 2002)
[Archived Article]
In Research Initiative/Treatment Action!, from The Center for AIDS
- Primary HIV Infection Case Presentations (Winter 2002)
[Archived Article]
In Research Initiative/Treatment Action!, from The Center for AIDS
- The Acute Infection and Early Disease Research Program (Winter 2002)
[Archived Article]
In Research Initiative/Treatment Action!, from The Center for AIDS
- Structured Treatment Interruptions (STI) in Patients Receiving HAART Since Primary HIV-1 Infection (PHI): Spontaneous Control of Viremia in Almost Half of Cases After the First Two Cycles Off Therapy (December 18, 2001)
[Archived Article]
In 41st Interscience Conference on Antimicrobial Agents and Chemotherapy (ICAAC 2001), from The Body PRO
- Greater Suppression of CD8 Activation with Four vs. Three Drugs in Early Stages of Primary HIV Infection (PHI) Despite Similar Plasma Virological Decay Rates (July 10, 2001)
[Archived Article]
In The 1st International AIDS Society Conference on HIV Pathogenesis and Treatment, from The Body PRO
- Clinical Features of Acute Retroviral Syndrome (ARS) by Gender and Age (February 6, 2001)
[Archived Article]
In The 8th Conference on Retroviruses and Opportunistic Infections, from The Body PRO
- Thymic Reconstitution in Primary HIV Infection (PHI) Following HAART Is Polyclonal (February 6, 2001)
[Archived Article]
In The 8th Conference on Retroviruses and Opportunistic Infections, from The Body PRO
- A Randomized Trial of Interleukin-2 (IL-2) Added to HAART for Primary HIV (February 6, 2001)
[Archived Article]
In The 8th Conference on Retroviruses and Opportunistic Infections, from The Body PRO
- The Effect of Pre-Treatment on Success of HAART Among Patients With Primary HIV (February 6, 2001)
[Archived Article]
In The 8th Conference on Retroviruses and Opportunistic Infections, from The Body PRO
- Recent Issues in Primary HIV: From Diagnosis to Oral Sex Transmission (November 7, 2000)
[Archived Article]
In The PRN Notebook
- Treatment with d4T + ddI + Nelfinavir + Hydroxyurea for Early or Recent Primary HIV Infection (February 2, 1999)
[Archived Article]
In The 6th Conference on Retroviruses and Opportunistic Infections, from The Body PRO
- Treatment of Primary HIV Infection with Zidovudine, Lamivudine and Indinavir: A Case-Control Study (September 25, 1998)
[Archived Article]
In The 38th Annual Meeting of the Interscience Conference on Antimicrobial Agents and Chemotherapy, from The Body PRO
- How Far Can You Knock Down HIV?: An Interview with David D. Ho, MD (June 1997)
[Archived Article]
In Journal of the International Association of Physicians in AIDS Care, from International Association of Physicians in AIDS Care
- Recipes for Failure (October 1996)
[Archived Article]
'Early' is right, they say, unless of course your regimen's wrong.
In TAGline, from Treatment Action Group
- Five-Drug or Six-Drug Antiretroviral Therapy -- Conversation with Steven Scheibel, M.D. (August 23, 1996)
[Archived Article]
In AIDS Treatment News, from AIDS Treatment News
- Primary Infection (Spring 1996)
[Archived Article]
In STEP Perspective, from Seattle Treatment Education Project
- Looking into the Future of HIV Therapy: An Interview with Dr. David Cooper (March, 1996)
[Archived Article]
In Journal of the International Association of Physicians in AIDS Care, from International Association of Physicians in AIDS Care
|
Advertisement
|
Email
Glossary
